Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Kenvue Inc. Common Stock (NY:KVUE)

15.09 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Kenvue Inc. Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
23 24 Next >
Why 3M Stock Was Moving Higher Today
Investors applauded the spin-off of its healthcare business. 
Via The Motley Fool
Should You Buy Solventum (SOLV) Stock After the 3M Spinoff?
Although 3M shareholders have reason to dump the Solventum spinoff, SOLV stock could be intriguing at the right price. 
Via InvestorPlace
How Is The Market Feeling About Kenvue?
 
Via Benzinga
3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff
Investors are split over the upcoming launch of 3M's healthcare spinoff, Solventum. What does the spinoff mean for 3M stock? 
Via InvestorPlace
Dear 3M Stock Fans, Mark Your Calendars for April 1
Investors are split on MMM stock ahead of 3M's long-awaited healthcare spinoff, Solventum, launching April 1. 
Via InvestorPlace
Should You Buy 3M Before April 1?
A looming stock spinoff should give investors a reason to pause. 
Via The Motley Fool
Looking Into Kenvue's Recent Short Interest
 
Via Benzinga
Earnings Scheduled For February 8, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million. 
Via Benzinga
7 Defensive Stocks to Build a Moat Around Your Portfolio
Although the market seems to continuously be on the rise, some concerning data suggests investors should consider defensive stocks. 
Via InvestorPlace
Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own
Investing in your golden years is about choosing stocks for retirees that are low-risk, offer passive income and steadily grow. 
Via InvestorPlace
Johnson & Johnson Stock Is Great. Here's Why You Shouldn't Buy It.
Johnson & Johnson's days of being a top healthcare stock could be long gone. 
Via The Motley Fool
The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough
Dive into tax season stocks, featuring dividend-rich JNJ and EQIX, plus growth-focused TSLA, for a smarter tax season strategy. 
Via InvestorPlace
7 High-Quality Blue-Chip Stocks to Buy if You’re Looking for Stability
With the market facing a possible rotation out of hot tech names, these stable blue-chip stocks may offer investors confidence. 
Via InvestorPlace
2 High-Yield Dow Jones Dividend Stocks to Buy Now and Hold Forever
These industry leaders boast advantages that could expand their bottom lines for decades. 
Via The Motley Fool
Topics Stocks
3 Dividend Aristocrat Stocks to Buy And Hold: March 2024
Buy-and-holder investors should fill their portfolios with these dividend aristocrat stocks to buy. These are some of the top names in the market. 
Via InvestorPlace
The Top 3 Blue-Chip Stocks to Buy in March 2024
Wager on these top blue-chip stocks to buy, striking an ideal balance between stability and growth for savvy long-term investors. 
Via InvestorPlace
Kenvue to Showcase 22 New Sets of Clinical Data at American Academy of Dermatology Association Meeting
From Kenvue Inc.
Via Business Wire
The Top 7 Dividend Stocks to Buy in March 2024
Bet on these top dividend stocks to buy for a resilient income flow and steady market gains, offering excellent balance. 
Via InvestorPlace
7 No-Frills Dividend Stocks for Your Must-Own List
Income investors don't need to invest in risky businesses when no-frills dividend stocks get the job done just fine. 
Via InvestorPlace
Secure Your Future: 7 Dividend Kings with Solid Growth Potential
Here are seven dividend kings that manage to deliver market-beating stock price growth in addition to their reliable, growing dividends. 
Via InvestorPlace
Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul
AAPL, AB InBev, and Johnson & Johnson are some of the best blue-chip stocks to buy and hold to fortify your investment portfolio. 
Via InvestorPlace
7 Stable Dividend Stocks to Ease Lingering Market Jitters
Although the economic coast seems clear, those who are still unsure can trust in the reliability of stable dividend stocks to buy. 
Via InvestorPlace
Kenvue to Present at the Consumer Analyst Group of New York Conference on February 23, 2024
From Kenvue Inc.
Via Business Wire
Why Is Consumer Health Firm Kenvue Stock Trading Lower Today?
Kenvue's Q4 2023 sales update: $3.67 billion, down 2.7%. Discover organic growth, net sales, and projections for fiscal year 2024. 
Via Benzinga
Kenvue (KVUE) Q4 2023 Earnings Call Transcript
KVUE earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Kenvue Reports Full Year and Fourth Quarter 2023 Results
From Kenvue Inc.
Via Business Wire
7 Dividend Stocks Worth Holding for the Long Haul
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly. 
Via InvestorPlace
The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024
Investors looking for reliable stocks that can be expected to continuously rise and provide strong returns should consider these names. 
Via InvestorPlace
Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now
Team up with the schoolyard bully so to speak with these compelling ideas for hedge fund favorite stocks to buy. 
Via InvestorPlace
Better Growth Stock: UnitedHealth Group vs. Johnson & Johnson
These companies have been focusing on growing their operations, but which stock is likely to provide investors with better returns? 
Via The Motley Fool
< Previous 1 2
...
8 9 10 11 12 13 14 15 16
...
23 24 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.